Jim Gaffigan has struggled with his weight for most of his adult life, but it seems that his most recent 50-lb weight loss is ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

Skipping your dose to over-indulge could leave you “excusing yourself from the table in a hurry,” an expert tells PEOPLE ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...